A novel ABCD1 G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review

Yu Zhang; Guoyong Zhang; Wenhui Chen; Zheng Pu; Lu Song; Xinghua Tang; Zhenguo Liu

doi:10.1016/j.gendis.2020.01.009

您当前的位置：

首页 >

文章列表页 >

A novel ABCD1 G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review

Full-length article | 更新时间：2022-06-24

- A novel ABCD1 G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review
- A novel ABCD1 G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review
- Genes & Diseases 2021年8卷第5期
- 作者机构：
  
  Department of Neurology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai,PR China,200092
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2020.01.009
  中图分类号：
- 纸质出版日期：2021，
  
  网络出版日期：2021-9-1，
扫描看全文
Yu Zhang, Guoyong Zhang, Wenhui Chen, 等. A novel ABCD1 G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review[J]. Genes & Diseases, 2021,8(5).

Yu Zhang, Guoyong Zhang, Wenhui Chen, et al. A novel ABCD1 G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review[J]. Genes & Diseases, 2021,8(5).
Yu Zhang, Guoyong Zhang, Wenhui Chen, 等. A novel ABCD1 G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review[J]. Genes & Diseases, 2021,8(5). DOI： 10.1016/j.gendis.2020.01.009.

Yu Zhang, Guoyong Zhang, Wenhui Chen, et al. A novel ABCD1 G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review[J]. Genes & Diseases, 2021,8(5). DOI： 10.1016/j.gendis.2020.01.009.

摘要

Abstract

drenomyeloneuropathy (AMN) is a kind of varied disease caused by

ABCD1

gene mutation and characterized by very-long-chain fatty acids (VLCFA) accumulation. It is diagnosed by clinical features

high VLCFAs levels and

ABCD1

gene mutation. AMN is rarely reported in Chinese population. In this study

we report the genetic and clinical features of a Chinese pure AMN patient. Meanwhile

we conducted a literature review of AMN cases to summarize the characteristics of AMN. We report a rare Chinese pure AMN case with slowly progressive weakness of the lower extremities

caused by a novel c.1202G

A mutation in

ABCD1

gene. The literature review indicates that spastic paraplegia is the mainly clinical manifestation in patients with AMN. VLCFAs and

ABCD1

gene test should be performed in patients with spastic paraplegia of the lower limbs to diagnose AMN.

关键词

Keywords

ABCD1geneAdrenomyeloneuropathyChinaMutationVery-long-chain fatty acids

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

CRISPR/Cas9 system and its applications in nervous system diseases

Genetic profiles of familial late-onset Alzheimer's disease in China: The Shanghai FLOAD study

Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera

The R168G heterozygous mutation of tropomyosin 3 (TPM3) was identified in three family members and has manifestations ranging from asymptotic to serve scoliosis and respiratory complications

Clinical phenotype of a Chinese patient with RIPK1 deficiency due to novel mutation